staurosporine has been researched along with Diabetic Nephropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartels, J; Haller, H; Kiyan, Y; Laudeley, R; Meier, M; Menne, J; Park, JK; Shushakova, N | 1 |
| Shibasaki, M; Tahara, A; Tomura, Y; Tsukada, J; Yatsu, T | 1 |
| Bomford, J; Frighi, V; Garrido, MC; Ng, LL; Simmons, D | 1 |
3 other study(ies) available for staurosporine and Diabetic Nephropathies
| Article | Year |
|---|---|
Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Isoenzymes; Kidney; Male; Mice; Mice, Knockout; Organ Size; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Staurosporine | 2013 |
Effects of high glucose on AVP-induced hyperplasia, hypertrophy, and type IV collagen synthesis in cultured rat mesangial cells.
Topics: Animals; Antidiuretic Agents; Arginine Vasopressin; Cells, Cultured; Collagen Type IV; Diabetic Nephropathies; Enzyme Inhibitors; Glomerular Mesangium; Hyperglycemia; Hyperplasia; Hypertrophy; Mesangial Cells; Rats; Rats, Wistar; Staurosporine | 2012 |
Effect of protein kinase C modulators on the leucocyte Na+/H+ antiport in type 1 (insulin-dependent) diabetic subjects with albuminuria.
Topics: Albuminuria; Alkaloids; Amiloride; Blood Glucose; Carrier Proteins; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycated Hemoglobin; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Insulin; Kinetics; Leukocytes; Protein Kinase C; Sodium-Hydrogen Exchangers; Staurosporine | 1990 |